HomeLEXX • NASDAQ
add
Lexaria Bioscience Corp
Previous close
$0.99
Day range
$0.95 - $1.06
Year range
$0.46 - $1.69
Market cap
25.40M USD
Avg Volume
180.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Feb 2026info | Y/Y change |
|---|---|---|
Revenue | 20.00K | -88.51% |
Operating expense | 1.47M | -49.68% |
Net income | -1.45M | 46.56% |
Net profit margin | -7.25K | -364.94% |
Earnings per share | — | — |
EBITDA | -1.43M | 47.87% |
Effective tax rate | -0.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Feb 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.27M | -19.46% |
Total assets | 6.49M | -25.24% |
Total liabilities | 277.00K | -85.55% |
Total equity | 6.21M | — |
Shares outstanding | 24.79M | — |
Price to book | 3.65 | — |
Return on assets | -57.90% | — |
Return on capital | -66.42% | — |
Cash Flow
Net change in cash
| (USD) | Feb 2026info | Y/Y change |
|---|---|---|
Net income | -1.45M | 46.56% |
Cash from operations | -2.16M | -44.46% |
Cash from investing | -53.91K | -93.26% |
Cash from financing | 3.04M | 25,873.16% |
Net change in cash | 846.91K | 152.63% |
Free cash flow | -1.74M | -153.21% |
About
Founded
2004
Website
Employees
7
